Suchergebnisse - "Qiqi Gao"

PubPharm (14)

1

Progress of Ginsenoside Rb1 in neurological disorders

in: Frontiers in Pharmacology | 2024

von Gongxia Ling | Min Zhang | Chizhang Chen | +7

2

Preparation and performance of magnetic zirconium-iron oxide nanoparticles loaded on palygorskite in the adsorption of phosphate from water

in: Química Nova | 2023

von Xiaoshuang Song | Yanling Hao | Qiqi Gao | +1

3

Macroinvertebrate community structure, pollution tolerance, diversity and feeding functional groups in polluted urban rivers under different black and odorous levels

in: Ecological Indicators | 2023

von Qiqi Gao | Qiqi Zhang | Jie Zeng | +4

4

Clinical characteristics and prognostic analysis of acute necrotizing encephalopathy of childhood: a retrospective study at a single center in China over 3 years

in: Frontiers in Neurology | 2023

von Yu Fang | Yu Fang | Qiqi Gao | +14

5

3D biofabrication of diseased human skin models in vitro

in: Biomaterials Research | 2023

von Minjun Ahn | Won-Woo Cho | Wonbin Park | +6

6

The Biofabrication of Diseased Artery In Vitro Models

in: Micromachines | 2022

von Chen Pan | Qiqi Gao | Byoung-Soo Kim | +2

7

Allergic Bronchopulmonary Mycosis Caused by Mucor Overlapping With Invasive Pulmonary Mucormycosis: A Case Report

in: Frontiers in Medicine | 2022

von Ruhui Zhang | Ge Jin | Yasheng Zhan | +6

8

Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy

in: Cancers | 2022

von Yulong Zheng | Qiqi Gao | Xingyun Su | +9

9

Author Correction : Eosinophils may serve as CEA-secreting cells for allergic bronchopulmonary aspergillosis (ABPA) patients

enthalten in: Scientific reports | 2021

von Yang, Y. | Qiqi, G. | Jin, Y. | +3

ErratumFor: Sci Rep. 2021 Feb 17;11(1):4025. - PMID 33597608

10

Eosinophils May Serve as CEA-Secreting Cells for ABPA Patients

enthalten in: ResearchSquare.com | 2021

von yanfei, Y. | qiqi, G. | yangyi, J. | +3